apolipoprotein E (Bio-Technology General)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameapolipoprotein E (Bio-Technology General)
Drug Alias Nameapolipoprotein Eapo-A4 (Bio-Technology General)Apo-E (Bio-Technology General)apolipoprotein-A4 (Bio-Technology General)apo-A4
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApolipoprotein E agonists
TargetsApolipoprotein E
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSavient Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSavient Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A